Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. (Q48222290)

9 February 2018

title

Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. (English)

1 reference

9 February 2018

0 references

0 references

Fabiola Olivieri

5

0 references

Eliezer Masliah

8

object named as

Eliezer Masliah

1 reference

9 February 2018

9

Claudio Franceschi

1 reference

9 February 2018

author name string

Federico Licastro

1

1 reference

9 February 2018

Luigi Maria Edoardo Grimaldi

2

1 reference

9 February 2018

Massimiliano Bonafè

3

1 reference

9 February 2018

Chiappelli Martina

4

1 reference

9 February 2018

Luca Cavallone

6

1 reference

9 February 2018

Simona Giovanietti

7

1 reference

9 February 2018

publication date

1 November 2003

1 reference

9 February 2018

published in

Neurobiology of Aging

1 reference

9 February 2018

volume

24

1 reference

9 February 2018

issue

7

1 reference

9 February 2018

page(s)

921-926

1 reference

9 February 2018

Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Association between an interleukin-6 promoter and 3' flanking region haplotype and reduced Alzheimer's disease risk in a German population.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Patterns of gliosis in Alzheimer's disease and aging cerebrum

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Rapid detection and sequencing of alleles in the 3' flanking region of the interleukin-6 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Interleukin-6: a cytokine for gerontologists

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Increased cytokine production in mononuclear cells of healthy elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Association of early-onset Alzheimer's disease with an interleukin-1? gene polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Physiological and pathological roles of interleukin-6 in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor rece

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Increased levels of alpha-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Gene polymorphism affecting α1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

The importance of inflammatory mechanisms in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Glial cytokines in Alzheimer's disease: review and pathogenic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Apolipoprotein E polymorphism and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

The genetics of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Effects of IL6 and IL1beta on aFGF expression and excitotoxicity in NT2N cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900013-7

7 January 2021

10.1016/S0197-4580(03)00013-7

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

12928051

1 reference

9 February 2018